# Safety and Efficacy of Dinoprostone (Propess) in the Women With Premature Rupture of Membrane or Gestational Age <38

> **NCT01916291** · PHASE2 · COMPLETED · sponsor: **Seoul National University Hospital** · enrollment: 189 (actual)

## Conditions studied

- Induction of Labor

## Interventions

- **DRUG:** Propess insertion group

## Key facts

- **NCT ID:** NCT01916291
- **Lead sponsor:** Seoul National University Hospital
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2013-08-25
- **Primary completion:** 2018-08-14
- **Final completion:** 2019-04-04
- **Target enrollment:** 189 (ACTUAL)
- **Last updated:** 2020-03-24


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01916291

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01916291, "Safety and Efficacy of Dinoprostone (Propess) in the Women With Premature Rupture of Membrane or Gestational Age <38". Retrieved via AI Analytics 2026-05-25 from https://api.ai-analytics.org/clinical/NCT01916291. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*